GL1X · GenesisL1 explorer

MolNFT v1 · #14140 · protein

Structural changes of the active site cleft and different saccharide binding modes in human lysozyme co-crystallized with hexa-N-acetyl- chitohexaose at pH 4.0

1LZR: “Structural changes of the active site cleft and different saccharide binding modes in human lysozyme…”. X-ray diffraction, 2 ligands (NAG, CL), 1 pocket (best druggability 0.35). MolNFT v1 #14140 on GenesisL1: 3D structure, binding…

PDB
1LZR
Type
protein
Length
130 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human lysozyme
EC
3.2.1.17
UniProt
P00695
Ligands
NAG, CL
Pockets
1 · best druggability 0.35

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman lysozyme (EC 3.2.1.17)protein13039% helix, 12% strandP00695

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.350.7516NAG

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1LZR · Structural changes of the active site cleft and different saccharide binding modes in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.